SynthesisJournal of the Egyptian National Cancer Institute2026
Efficacy and safety of antibody-drug conjugates in HER2-positive and HER2-low advanced gastric cancer: a systematic review and update.
Lili Lei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.